HBV Mutation Detail Information

> M204V Search Result


Mutation Information
Mutation Site M204V
Mutation Type Amino acid level
Gene/Protein/Region Type RT
Genotype/Subtype A
Relevant Drug lamivudine (LAM)
Literature Information
PubMed PMID 18036104
Disease Chronic hepatitis B
Published Year 2007
Journal Liver international : official journal of the International Association for the Study of the Liver
Title Efficacy of hepatitis B virus (HBV) vaccination in treating lamivudine-resistant HBV reactivation following hepatitis B surface antigen seroconversion.
Author Gérolami R,Borentain P,Colson P,Norguet E,Gérolami A,Tamalet C
Evidence Due to the presence of rtM204V resistance mutation, lamivudine was not reintroduced and the patient was treated by HBsAg vaccination.

Contents
Description
Mutation Information Note
  • Gene/Protein/Region Type: Virus Gene (e.g. LMP-1) or Virus Protein (e.g. Rep 68) or Virus Region (e.g. S, X)
Literature Information Note
  • Evidence: sentence contains this mutation information in the citation